Pleomorphic adenoma secondary prevention: Difference between revisions

Jump to navigation Jump to search
 
(5 intermediate revisions by the same user not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Pleomorphic adenoma}}
{{Pleomorphic adenoma}}
{{CMG}}; {{AE}}  
{{CMG}}; {{AE}} {{M.N}}


==Overview==
==Overview==
Effective measures for the [[secondary prevention]] of pleomorphic adenoma include timely [[Radiological|radiologic]] [[imaging]], [[blood tests]], avoiding [[Working area|working]] at risk environments like rubber and [[asbestos]] industries, minimizing [[head]] and [[neck]] [[irradiation]] as much as possible.
Effective measures for the [[secondary prevention]] of pleomorphic adenoma include timely [[physical examination]], [[Radiological|radiologic]] [[imaging]], [[blood tests]].


==Secondary Prevention==
==Secondary Prevention==
*Secondary preventive measures include timely [[screening]] at regular intervals with routine [[physical examination]], [[radiological]] [[imaging]], and [[blood tests]].  
*Secondary preventive measures include timely [[screening]] at regular intervals with routine [[physical examination]], [[radiological]] [[imaging]], and [[blood tests]].  
*Individuals those who are [[Working area|working]] in rubber and [[asbestos]] industries should be advised to seek an alternative job.
*If possible advise the [[patients]] to minimize unnecessary [[radiation]] exposure to [[head]] and [[neck]] region.
*Once diagnosed and successfully treated, [[patients]] with pleomorphic adenoma are followed-up every 6 or 12 months.
*Once diagnosed and successfully treated, [[patients]] with pleomorphic adenoma are followed-up every 6 or 12 months.


Line 17: Line 15:
{{WH}}
{{WH}}
{{WS}}
{{WS}}
[[Category: (name of the system)]]
 
[[Category: Otolaryngology]]
[[Category: Medicine]]
[[Category: Oncology]]
[[Category: Surgery]]
[[Category: Up-To-Date]]

Latest revision as of 20:30, 28 January 2019

Pleomorphic adenoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Pleomorphic adenoma from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

CT scan

MRI

Echocardiography and Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Pleomorphic adenoma secondary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Pleomorphic adenoma secondary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pleomorphic adenoma secondary prevention

CDC on Pleomorphic adenoma secondary prevention

Pleomorphic adenoma secondary prevention in the news

Blogs on Pleomorphic adenoma secondary prevention

Directions to Hospitals Treating Pleomorphic adenoma

Risk calculators and risk factors for Pleomorphic adenoma secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Maneesha Nandimandalam, M.B.B.S.[2]

Overview

Effective measures for the secondary prevention of pleomorphic adenoma include timely physical examination, radiologic imaging, blood tests.

Secondary Prevention

References

Template:WH Template:WS